NCT00453635 Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients Status TERMINATED Phase PHASE2
NCT00452985 Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer Status COMPLETED Phase N/A
NCT00452920 Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT00450008 Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer Status TERMINATED Phase PHASE2
NCT00449020 Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00448760 Combination Chemotherapy in Treating Patients With Previously Untreated Stage II or Stage III Esophageal Cancer That Can Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00448734 A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT00448682 Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By Surgery Status TERMINATED Phase PHASE2
NCT00448097 Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy Status TERMINATED Phase PHASE2
NCT00446225 Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFR Status COMPLETED Phase PHASE3
NCT00446030 Pilot Study of the Safety & Efficacy of Two Docetaxel-Based Regimens Plus Bevacizumab for the Adjuvant Treatment of Subjects With Node Positive or High Risk Node Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT00442026 Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLC Status TERMINATED Phase PHASE3
NCT00441922 Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE3
NCT00441740 Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00440128 The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer Status COMPLETED Phase PHASE1
NCT00439270 Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00436839 Taxotere Prostate Cancer New Indication Registration Trial in China Status COMPLETED Phase PHASE3
NCT00436501 VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Status COMPLETED Phase PHASE1/PHASE2